European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
about
Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native populationLow prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010HIV-1 pol diversity among female bar and hotel workers in Northern TanzaniaA very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAARTPerformance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in CubaTransmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in IranAn Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 QuasispeciesHumanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1HIV-1 Genetic Variability and Clinical ImplicationsPrediction of HIV drug resistance from genotype with encoded three-dimensional protein structureThe global spread of HIV-1 subtype B epidemic.An affordable HIV-1 drug resistance monitoring method for resource limited settingsPhylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men.Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencingPrevalence and virologic consequences of transmitted HIV-1 drug resistance in UgandaHIV-1 antiretroviral resistance: scientific principles and clinical applicationsHIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland.Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy response.Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialJapanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material.Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals.Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance.HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates.Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.Transmitted HIV drug resistance in treatment-naive Romanian patientsRecent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.Transmitted drug resistance to rilpivirine among antiretroviral-naïve patients living with HIV from northern Poland.HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing.Decoding HIV resistance: from genotype to therapy.Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation.In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants.
P2860
Q28477624-6E35965E-B840-445F-B989-13C5F45AD8D8Q28481603-74508782-40D5-414C-8F23-F96B873221F2Q28540536-A0A87296-5F10-4063-930B-F41E6672D370Q28542548-F856E98E-79F7-45ED-AF07-9CC23CDD599DQ28543384-4487FC2C-5DFA-4B4F-9AA9-5C886224FB97Q28547171-1DD96DA4-DC27-441F-9FF6-7959DDCD35C0Q28554999-C5878F59-F294-4C7F-89F7-9A70A5DEAF8EQ28728527-D37186F8-AC3F-4BBA-A260-FC05988D7651Q30352010-F977BE0E-57A0-4BBD-B4F1-328FDE571F50Q30365343-A6F689E5-BE75-4342-9D05-BB12760D0E62Q30388926-90E9C945-B749-4A35-87FD-D3CFFC5C2D57Q30486897-7D794FB7-2158-4A0E-AF0D-43236857F6ADQ30670919-2058C35B-4B8A-493E-94A8-95C365F777FEQ33828355-77AD9234-DFF5-40BE-88EC-E50DA28222E3Q33899918-4759804B-84C0-49A2-8BB0-57971E194607Q34116836-F07F9BCC-BD8A-48A1-B8AA-7F123B3AE1B8Q34280466-08C27CBC-175E-4D9C-BE46-3959DF4956A0Q34520239-55DF06D5-553A-4EDD-A3C8-D50C8279F711Q34684386-50741152-71EF-4ED1-B468-9B2AEEB9D6ECQ35124860-B53FE306-BA9F-4BEB-AC55-A133E1110E23Q35141797-7E78D2C8-BF80-4E64-AC9C-87B85C817316Q36061979-C5ED56AA-EB39-43BB-B33E-5478084E5E16Q36096436-DEC4CC1B-7D61-4CFB-BC4B-5BDA3374CA2DQ36406860-2940F9CE-5FCC-47F7-AD66-5904017435D9Q36414162-B877FD26-1B14-4817-B48A-8B16D41397D8Q36553927-84D0185F-8180-46D4-91B7-5DDC676528EDQ36933330-11B4047D-0632-4C5E-821F-DCD52C561C18Q37147719-9B41C06F-13A0-4AFB-86B4-4F33B9AC7428Q37495405-D0010779-10CF-466B-ADB5-41594F06AC45Q37631865-E86185D8-A1A9-4709-BBD2-EFE8A742613BQ37634044-FA9A8EE7-9D97-435C-885A-0CC9D371B574Q37643256-31C19C85-A652-4D6E-BE1B-E5D251F5E662Q37710424-12F15613-5504-44F6-9C47-DE68E6AD3A27Q38375479-2A5A1C54-567C-487E-A4E0-29051D8AAE5AQ38632663-4FE09C80-E9DE-453F-89FF-5D356F050E4FQ40104085-02E80551-7D04-43CD-A8B5-E5B9364A4C65Q40988716-C4ABCC24-CFBA-4C33-8B26-42B9787F739A
P2860
European recommendations for the clinical use of HIV drug resistance testing: 2011 update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
European recommendations for t ...... sistance testing: 2011 update.
@en
European recommendations for t ...... sistance testing: 2011 update.
@nl
type
label
European recommendations for t ...... sistance testing: 2011 update.
@en
European recommendations for t ...... sistance testing: 2011 update.
@nl
prefLabel
European recommendations for t ...... sistance testing: 2011 update.
@en
European recommendations for t ...... sistance testing: 2011 update.
@nl
P2093
P50
P1433
P1476
European recommendations for the clinical use of HIV drug resistance testing: 2011 update
@en
P2093
Anders Sönnerborg
Andreu de Luca
Anne-Mieke Vandamme
Dimitrios Paraskevis
European HIV Drug Resistance Guidelines Panel
Francesca Ceccherini-Silberstein
Hauke Walter
Jean-Claude Schmit
Lucia Palmisano
Mario Poljak
P304
P577
2011-04-01T00:00:00Z